FOR IMMEDIATE RELEASE
Industry’s First Unified Clinical Data Management Platform With Local Language
Translation and Double Data Entry Features Showcased at Booth #147
NEW YORK, NY – March 30, 2006 – Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced that its product, Rave 5.5 was named as a finalist in the Clinical Trials and Research category for Bio-IT World Magazine’s Best of Show Award to be presented at the Life Sciences Conference + Expo, April 3–5, 2006.
The industry’s first unified clinical data management platform designed for biopharmaceutical companies, medical device and research organizations, Rave 5.5 eliminates the costly and time-consuming procedures traditionally faced by sponsors when deploying all types of global trials—including Phase I, II, III, IV and registries/surveillance studies. Using Rave 5.5’s Local Language Translation Workbench, sponsors are now able to capture, manage and report on clinical data in the language of their choice and gain earliest visibility into critical data to drive better decision-making. Rave 5.5’s Double Data Entry (DDE) features allow for paper and paper/EDC hybrid studies to be run on a common web-based, enterprise-level platform.
Cambridge Healthtech Institute’s Bio-IT World is a premier B-to-B publication addressing the technologies driving discovery, development and clinical trials. Judged by a team of Bio-IT World magazine editors and leading industry experts, the awards program spotlights new products that demonstrate exceptional technology innovation across the life sciences research, discovery and clinical trials process. Finalists were chosen among entries submitted from leading bio-IT vendors exhibiting at the conference and expo, based on the products’ technical merit, functionality and innovation. Products considered as finalists are new products or significant product upgrades introduced between May 2005 and April 2006.
“Selected by prominent judges with years of experience in the bio-science fields, the Life Sciences Conference + Expo’s Best of Show Awards finalists consist of products within IT, informatics and life science technologies that have captured the attention of our judges because of their innovation and leadership in their respective markets,” said John Russell, executive editor, Bio-IT World. “These awards recognize the products that are fueling tomorrow’s discoveries.”
One winner in each category will be selected after judges have reviewed the products on the show floor at the Life Sciences Conference + Expo. Executive Editor of Bio-IT World, John Russell, will present the awards at a ceremony on April 4 at 6:00 pm. held on the Expo floor, which is open to all attendees, exhibitors and members of the press. Winners of the Best of Show Awards will receive honorary signage, an awards logo and an engraved award. They also will be featured on the Bio-IT World web site with additional coverage in an upcoming issue of the magazine. For complete coverage of the awards, along with continuous updates from Boston’s Life Sciences Conference + Expo by Bio-IT World editors, visit www.bio-itworld.com.
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology and medical device companies realize the maximum potential value from their clinical research investments. Working with companies large and small, Medidata Solutions helps accelerate the process of bringing life-enhancing treatments to market—on five continents and in more than 70 countries. Innovative process design, technology and services can streamline clinical trials by providing early visibility to clinical data for faster decision-making, optimized resources and lower execution risk. Medidata Solutions’ broad client base and deep clinical experience provide value for the world’s leading pharmaceutical, biotechnology and medical device companies, expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. To learn more about Medidata Solutions, please visit www.mdsol.com.
About Bio-IT World, Inc.
Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT professionals. Coverage focuses on the application of technology products and services to enable the life sciences R&D value chain in pharmaceutical, biotechnology, healthcare, government and academic research organizations, spanning basic research, drug discovery and development, clinical trials, and regulatory compliance. The company’s premier publication, Bio-IT World and accompanying website, www.bio-itworld.com, deliver the latest news, analysis and information on the indispensable technologies driving innovation in the bio-IT community. Bio-IT World also produces the Life Sciences Conference + Expo, now in it’s fifth year, along with supporting multiple industry events as strategic and business partners. Bio-IT World has received more than 34 awards for editorial and design excellence. Established in September 2001, Bio-IT World, Inc., headquartered in Framingham, MA., is a business of Cambridge Healthtech Institute.
About Cambridge Healthtech Institute
CHI’s renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences held throughout the US. including The Molecular Medicine Tri-Conference, Beyond Genome, PepTalk, World Pharmaceutical Congress and the new acquired Bio-IT World’s Life Sciences Conference & Expo. The company strives to develop quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. Leading researchers and business experts from top pharmaceutical, biotech and academic organizations present their most current findings in a forum that features panel discussions and audience participation. Over the past 14 years, CHI has produced more than 400 conferences, attracting more than 50,000 attendees from around the world.
In addition to CHI’s vast conference portfolio, their media properties include PharmaWeek, available on the web only, Pharmaceutical Discovery which will relaunch in print and online in May following its acquisition last year from Advanstar Communications and Bio-IT World acquired in March 2006.
Contact:
Susan Lombardo
Lois Paul & Partners
781.782.5767
Susan_Lombardo@lpp.com